A Multicenter, Double-Blind, Randomized, Cross-Over Study Evaluating Pharmacodynamic Activity of E2730 in Adult Subjects With Photosensitive Epilepsy
Phase of Trial: Phase II
Latest Information Update: 23 Jan 2019
At a glance
- Drugs E 2730 (Primary)
- Indications Epilepsy
- Focus Pharmacodynamics
- Sponsors Eisai Inc
- 15 Jan 2019 Status changed from recruiting to discontinued.
- 16 Oct 2018 Planned End Date changed from 19 Dec 2018 to 11 Feb 2019.
- 16 Oct 2018 Planned primary completion date changed from 19 Dec 2018 to 11 Feb 2019.